Blog
09
Jan
Greenstone Biosciences is proud to be a sponsor of the 2023 Stanford Drug Discovery Symposium
Greenstone Biosciences is a proud sponsor of the 2023
27
Sep
Greenstone Biosciences Secures $2.75M to Advance Revolutionary Cardiotoxicity Detection Technology
Published: Sep 13, 2023
PALO ALTO, CA — September 12, 2023 — Greenstone Biosc...
13
Jul
Congratulation to Greenstone Biosciences co-founder for becoming the President of American Heart Association
Greenstone Biosciences is excited to announce that our distinguished co-founder, Dr. Jo...
01
Feb
Greenstone Biosciences on a Quest for Duchenne Muscular Dystrophy Therapeutics with New Funding from CIRM
Palo Alto, CA, February 1, 2023 – Recently, the California Institute of Regenerative Me...
12
Dec
Greenstone co-founder Joseph Wu inducted into NAI Class of 2022
We want to congratulate our co-founder
07
Dec
CIRM funds Greenstone Biosciences with $1.35M to accelerate drug discovery using patient – derived induced pluripotent stem cells
Greenstone Biosciences, Inc., a computational biology driven drug discovery company,
01
Dec
Greenstone Bio adds Axel Brunger to the Scientific Advisory Board
Greenstone Biosciences would like to welcome Axel Brunger of Stanfo...
13
Oct
CIRM Awards $1.3 million to Greenstone Bio for Innovative Cardiovascular Stem Cell Research
Palo Alto, CA, October 04, 2022 – Greenstone Biosciences, Inc. (“Greenstone Bio”),...
23
Aug
Greenstone Biosciences, Inc. Announces Collaboration with the Maryland Stem Cell Research Fund to Provide Curated Induced Pluripotent Stem Cell Lines to Stem Cell Investigators Across the State of Maryland
The stem cell lines provided through this collaboration empower Maryland stem cell scie...